Danske Bank
25
119M
20
0.16
7
0.20
10
- Areas of investment
Summary
In 1871 was created Danske Bank, which is appeared as Corporate Investor. The fund was located in Europe if to be more exact in Denmark. The leading representative office of defined Corporate Investor is situated in the Copenhagen.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The increased amount of exits for fund were in 2014. Comparing to the other companies, this Danske Bank performs on 9 percentage points less the average number of lead investments. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this Corporate Investor is 20 percentage points more often commits exit comparing to other companies.
The standard case for the fund is to invest in rounds with 5-6 partakers. The meaningful sponsors for the fund in investment in the same round are DNB, Westpac, Wells Fargo. In the next rounds fund is usually obtained by Index Ventures, SLS Venture, Novo Holdings.
The overall number of key employees were 25.
Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Financial Services, Biopharma. Among the most popular portfolio startups of the fund, we may highlight R3, Devenish Nutrition, Gilfresh Produce. For fund there is a match between the location of its establishment and the land of its numerous investments - Denmark.
Investments analytics
Analytics
- Total investments
- 25
- Lead investments
- 7
- Exits
- 10
- Rounds per year
- 0.16
- Follow on index
- 0.20
- Investments by industry
- Banking (6)
- Payments (4)
- Information Technology (4)
- Real Estate (4)
- Biotechnology (3) Show 40 more
- Investments by region
-
- Sweden (8)
- Denmark (11)
- United Kingdom (2)
- United States (2)
- Finland (1) Show 1 more
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 27
- Avg. valuation at time of investment
- 192K
- Group Appearance index
- 0.64
- Avg. company exit year
- 30
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Symphogen | 22 Jan 2002 | Biotechnology, Drug Discovery, Pharmaceutical, Biopharma | Early Stage Venture | 15M | Denmark, Capital Region of Denmark, Denmark |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.